Logo

Lion s Revenues Tank, Losses Narrow in Q4 of FY2003/2004

May 04, 2004

NEW YORK, May 4 (GenomeWeb News) - Lion Bioscience revenues took a nosedive, while its losses narrowed during its fourth quarter of fiscal year 2003/2004, which ended March 31. The company reported preliminary results for the quarter today.

 

Lion's revenues plummeted to €3.1 million ($3.7 million), from €9 million ($10.9 million) during the same quarter a year ago.

 

The company's net loss totaled €4.9 million, down from €18.5 million during the same period last year.

 

As of March 31, Lion had €43.1 million in cash and cash equivalents.

Breaking News
The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.